{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:54Z","timestamp":1790190774594,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s8915","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T02:37:47Z","timestamp":1300761467000},"page":"151","source":"Crossref","is-referenced-by-count":75,"title":["Current and emerging therapies for the treatment of myasthenia gravis"],"prefix":"10.2147","author":[{"given":"Renato","family":"Mantegazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,3]]},"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=9355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:03:25Z","timestamp":1477865005000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/current-and-emerging-therapies-for-the-treatment-of-myasthenia-gravis-peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ndt.s8915","relation":{},"ISSN":["1176-6328"],"issn-type":[{"value":"1176-6328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}